Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05CSS
|
|||
| Drug Name |
CAR-T cells targeting MucI
|
|||
| Drug Type |
CAR T Cell Therapy
|
|||
| Indication | Lung cancer [ICD-11: 2C25.0; ICD-9: 162] | Phase 1/2 | [1] | |
| Glioblastoma multiforme [ICD-11: 2A00.0; ICD-9: 191] | Phase 1 | [2] | ||
| Company |
Shenzhen Geno-Immune Medical Institute
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Mucin-1 (MUC1) | Target Info | CAR-T-Cell-Therapy | [1], [2] |
| WikiPathways | Hematopoietic Stem Cell Differentiation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03356808) Antigen-specific T Cells Against Lung Cancer | |||
| REF 2 | ClinicalTrials.gov (NCT03170141) Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.